{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:30:24Z","timestamp":1776832224221,"version":"3.51.2"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Three classes of IgG have been described for camelids. IgG1 has a conventional four-chain structure, while IgG2 and IgG3 do not incorporate light chains. The structures and antigen-binding affinities of the so-called heavy-chain classes have been studied in detail; however, their regulation and effector functions are largely undefined. The aim of this study was to examine the participation of conventional and heavy-chain IgG antibodies in the camelid immune defense directed against West Nile virus (WNV). We found that natural infection or vaccination with killed WNV induced IgG1 and IgG3. Vaccination also induced IgG1 and IgG3; IgG2 was produced during the anamnestic response to vaccination. When purified IgGs were tested in plaque-reduction neutralization titer (PRNT) tests, IgG3 demonstrated PRNT activities comparable to those of conventional IgG1. In contrast, IgG2 demonstrated only suboptimal activity at the highest concentrations tested. Flow cytometric analysis revealed that macrophages bound IgG1, IgG2, and IgG3. Furthermore, subneutralizing concentrations of all three isotypes enhanced WNV infection of cultured macrophages. Our results document distinctions in regulation and function between camelid heavy-chain isotypes. The reduced size and distinct structure of IgG3 did not negatively impact its capacity to neutralize virus. In contrast, IgG2 appeared to be less efficient in neutralization. This information advances our understanding of these unusual antibodies in ways that can be applied in the development of effective vaccines for camelids.<\/jats:p>","DOI":"10.1128\/cvi.00421-09","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T03:25:34Z","timestamp":1259810734000},"page":"239-246","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Effector Functions of Camelid Heavy-Chain Antibodies in Immunity to West Nile Virus"],"prefix":"10.1128","volume":"17","author":[{"given":"L. P.","family":"Daley","sequence":"first","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Kutzler","sequence":"additional","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"Bennett","sequence":"additional","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Smith","sequence":"additional","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Glaser","sequence":"additional","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Appleton","sequence":"additional","affiliation":[{"name":"James A. Baker Institute for Animal Health"},{"name":"Animal Health Diagnostic Laboratory"},{"name":"Population Medicine &amp; Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.24.13097-13100.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.133.2.969","volume":"133","year":"1984","unstructured":"Bjorck, L., and G. Kronvall. 1984. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J. Immunol.133:969-974.","journal-title":"J. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","year":"1990","unstructured":"Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol.44:649-688.","journal-title":"Annu. Rev. Microbiol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1021\/bi8005797","volume":"47","year":"2008","unstructured":"Chan, P. H., E. Pardon, L. Menzer, E. De Genst, J. R. Kumita, J. Christodoulou, D. Saerens, A. Brans, F. Bouillenne, D. B. Archer, C. V. Robinson, S. Muyldermans, A. Matagne, C. Redfield, L. Wyns, C. M. Dobson, and M. Dumoulin. 2008. Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. Biochemistry47:11041-11054.","journal-title":"Biochemistry"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","volume":"86","year":"2005","unstructured":"Chu, J. J., R. Rajamanonmani, J. Li, R. Bhuvanakantham, J. Lescar, and M. L. Ng. 2005. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol.86:405-412.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_7_2","first-page":"380","volume":"12","year":"2005","unstructured":"Daley, L. P., L. F. Gagliardo, M. S. Duffy, M. C. Smith, and J. A. Appleton. 2005. Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids. Clin. Diagn. Lab. Immunol.12:380-386.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-2427(00)00167-7","volume":"74","year":"2000","unstructured":"Davis, W. C., L. R. Heirman, M. J. Hamilton, S. M. Parish, G. M. Barrington, A. Loftis, and M. Rogers. 2000. Flow cytometric analysis of an immunodeficiency disorder affecting juvenile llamas. Vet. Immunol. Immunopathol.74:103-120.","journal-title":"Vet. Immunol. Immunopathol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0969-2126(99)80049-5","volume":"7","year":"1999","unstructured":"Decanniere, K., A. Desmyter, M. Lauwereys, M. A. Ghahroudi, S. Muyldermans, and L. Wyns. 1999. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure7:361-370.","journal-title":"Structure"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/jmbi.2000.3839","volume":"300","year":"2000","unstructured":"Decanniere, K., S. Muyldermans, and L. Wyns. 2000. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes? J. Mol. Biol.300:83-91.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"26285","DOI":"10.1074\/jbc.M102107200","volume":"276","year":"2001","unstructured":"Desmyter, A., K. Decanniere, S. Muyldermans, and L. Wyns. 2001. Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J. Biol. Chem.276:26285-26290.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsb0996-803","volume":"3","year":"1996","unstructured":"Desmyter, A., T. R. Transue, M. A. Ghahroudi, M. H. Thi, F. Poortmans, R. Hamers, S. Muyldermans, and L. Wyns. 1996. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat. Struct. Biol.3:803-811.","journal-title":"Nat. Struct. Biol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetimm.2005.10.003","volume":"110","year":"2006","unstructured":"Garcia-Tapia, D., C. M. Loiacono, and S. B. Kleiboeker. 2006. Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet. Immunol. Immunopathol.110:229-244.","journal-title":"Vet. Immunol. Immunopathol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1084\/jem.146.1.218","volume":"146","year":"1977","unstructured":"Halstead, S. B., E. J. O'Rourke, and A. C. Allison. 1977. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med.146:218-229.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","year":"1993","unstructured":"Hamers-Casterman, C., T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers, E. B. Songa, N. Bendahman, and R. Hamers. 1993. Naturally occurring antibodies devoid of light chains. Nature363:446-448.","journal-title":"Nature"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/icb.1964.44","volume":"42","year":"1964","unstructured":"Hawkes, R. A. 1964. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Aust. J. Exp. Biol. Med. Sci.42:465-482.","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2460\/javma.2004.225.414","volume":"225","year":"2004","unstructured":"Kutzler, M. A., R. J. Baker, and D. E. Mattson. 2004. Humoral response to West Nile virus vaccination in alpacas and llamas. J. Am. Vet. Med. Assoc.225:414-416.","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/emboj\/17.13.3512","volume":"17","year":"1998","unstructured":"Lauwereys, M., M. Arbabi Ghahroudi, A. Desmyter, J. Kinne, W. Holzer, E. De Genst, L. Wyns, and S. Muyldermans. 1998. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J.17:3512-3520.","journal-title":"EMBO J."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","volume":"3","year":"2005","unstructured":"Mukhopadhyay, S., R. J. Kuhn, and M. G. Rossmann. 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol.3:13-22.","journal-title":"Nat. Rev. Microbiol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","volume":"26","year":"2001","unstructured":"Muyldermans, S., C. Cambillau, and L. Wyns. 2001. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci.26:230-235.","journal-title":"Trends Biochem. Sci."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-5890(99)00067-X","volume":"36","year":"1999","unstructured":"Nguyen, V. K., R. Hamers, L. Wyns, and S. Muyldermans. 1999. Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IgG2A heavy-chain antibodies. Mol. Immunol.36:515-524.","journal-title":"Mol. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jmbi.1997.1477","volume":"275","year":"1998","unstructured":"Nguyen, V. K., S. Muyldermans, and R. Hamers. 1998. The specific variable domain of camel heavy-chain antibodies is encoded in the germline. J. Mol. Biol.275:413-418.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","volume":"310","year":"2005","unstructured":"Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science310:1510-1512.","journal-title":"Science"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","year":"2005","unstructured":"Oliphant, T., M. Engle, G. E. Nybakken, C. Doane, S. Johnson, L. Huang, S. Gorlatov, E. Mehlhop, A. Marri, K. M. Chung, G. D. Ebel, L. D. Kramer, D. H. Fremont, and M. S. Diamond. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med.11:522-530.","journal-title":"Nat. Med."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/S0074-02762003000200017","volume":"98","year":"2003","unstructured":"Saldarriaga, O. A., J. I. Velaquez, J. E. Ossa, and M. T. Rugeles. 2003. Standardization of bovine macrophage monolayers and isolation and culture of trypanosomes. Mem. Inst. Oswaldo Cruz98:269-271.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01118-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nsb0996-752","volume":"3","year":"1996","unstructured":"Spinelli, S., L. Frenken, D. Bourgeois, L. de Ron, W. Bos, T. Verrips, C. Anguille, C. Cambillau, and M. Tegoni. 1996. The crystal structure of a llama heavy chain variable domain. Nat. Struct. Biol.3:752-757.","journal-title":"Nat. Struct. Biol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"e1000453","DOI":"10.1371\/journal.ppat.1000453","volume":"5","year":"2009","unstructured":"Thompson, B. S., B. Moesker, J. M. Smit, J. Wilschut, M. S. Diamond, and D. H. Fremont. 2009. A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog.5:e1000453.","journal-title":"PLoS Pathog."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E","volume":"32","year":"1998","unstructured":"Transue, T. R., E. De Genst, M. A. Ghahroudi, L. Wyns, and S. Muyldermans. 1998. Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins32:515-522.","journal-title":"Proteins"},{"key":"e_1_3_2_30_2","first-page":"198","volume":"43","year":"1987","unstructured":"Ungar-Waron, H., E. Elias, A. Gluckman, and Z. Trainin. 1987. Dromedary IgG: purification, characterization, and quantification in sera of dams and newborns. Isr. J. Vet. Med.43:198-203.","journal-title":"Isr. J. Vet. Med."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-1759(00)00188-5","volume":"240","year":"2000","unstructured":"van der Linden, R., B. de Geus, W. Stok, W. Bos, D. van Wassenaar, T. Verrips, and L. Frenken. 2000. Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J. Immunol. Methods240:185-195.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00286-09"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M402385200","volume":"279","year":"2004","unstructured":"Volk, D. E., D. W. Beasley, D. A. Kallick, M. R. Holbrook, A. D. Barrett, and D. G. Gorenstein. 2004. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem.279:38755-38761.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0161-5890(97)00146-6","volume":"34","year":"1997","unstructured":"Vu, K. B., M. A. Ghahroudi, L. Wyns, and S. Muyldermans. 1997. Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol. Immunol.34:1121-1131.","journal-title":"Mol. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s002510050694","volume":"50","year":"1999","unstructured":"Woolven, B. P., L. G. Frenken, P. van der Logt, and P. J. Nicholls. 1999. The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation. Immunogenetics50:98-101.","journal-title":"Immunogenetics"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599794","volume":"200","year":"2009","unstructured":"Zhang, S., M. R. Vogt, T. Oliphant, M. Engle, E. I. Bovshik, M. S. Diamond, and D. W. Beasley. 2009. Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. J. Infect. Dis.200:202-205.","journal-title":"J. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00421-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00421-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:23:36Z","timestamp":1685215416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00421-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1128\/CVI.00421-09"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00421-09","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"2009-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-11-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}